通过饮食或额外补充剂增加钾摄入:一项适应性临床试验方案
该方案采用两阶段适应性设计,纳入经24小时尿检证实钾摄入不足的高血压患者,先接受个体化饮食建议及每周电话/邮件支持,4周时钾摄入未增加者加用钾补充剂,8周验证补充剂疗效,52周观察效果持续性,同时测量钠摄入、血压、满意度和安全性。
要点
- 高血压且24小时尿检证实钾摄入不足者先接受个体化饮食建议加每周支持。
- 4周时钾摄入未增加者加用钾补充剂,8周验证补充剂疗效。
- 52周观察饮食或补充剂效果的持续性,同时测量钠摄入、血压与安全性。
核心结论
- 研究结果将帮助确定增加钾摄入的最有效方法,从而降低血压和减少降压药物需求,并可能提高参与者满意度。
- 现行指南推荐通过饮食改变而非钾补充剂来增加钾摄入,因此两阶段设计仅在最严格的饮食建议无效时才加用补充剂。
研究设计与样本
- 两阶段适应性临床试验设计。
- 第一阶段:高血压且经24小时尿检证实钾摄入不足的参与者接受个体化饮食建议,并由每周电话/邮件支持强化。
- 4周时若未测得钾摄入增加,则处方额外钾补充剂。
- 8周再次检测以确认钾补充剂疗效,最终测量计划在52周以观察和测量饮食或额外补充剂效果的持续性。
主要发现
- 同时测量钠摄入、血压、参与者满意度和安全性措施。
关键数值与推荐
- 当前指南推荐通过饮食改变而非钾补充剂来增加钾摄入。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High blood pressure is the leading cause of cardiovascular disease worldwide. The prevalence of high blood pressure is steadily rising as the population grows amongst older adults with the ageing population. Therapeutical treatments are widely available to decrease blood pressures, in addition to many lifestyle options, such as dietary changes and exercise. There is a marked preference amongst patients, as reiterated by Hypertension Canada, for more research into non-therapeutic methods for controlling blood pressure or to reduce the burden of taking many pills to control high blood pressure. Indeed, effective options do exist, especially with diet, specifically decreasing sodium and increasing potassium intake. Current public health outreach primarily focusses on sodium intake, even though potassium intake remains low in the Western world. Excellent data exist in published research that increasing potassium intake, either via dietary modification or supplements, reduces blood pressure and reduces risk of cardiovascular outcomes such as stroke. However, the advice most often provided by medical professionals is to 'eat more fruits and vegetables' which has little impact on patient outcomes. METHODS: We propose to do a clinical trial in two stages with an adaptive trial design. In the first stage, participants with high blood pressure and proven low potassium intake (measured on the basis of a 24-h urine collection) will get individually tailored dietary advice, reinforced by weekly supportive phone/email support. At 4 weeks, if there has not been a measured increase in potassium intake, participants will be prescribed an additional potassium supplement. Testing will be conducted again at 8 weeks, to confirm the efficacy of the potassium supplement. Final measurements will be planned at 52 weeks to observe and measure the persistence of the effect of diet or additional supplement. Concurrent measurements of sodium intake, blood pressure, participant satisfaction, and safety measures will also be done. DISCUSSION: The results of the study will help determine the most effective method of increasing potassium intake, thus reducing blood pressure and need for blood pressure-lowering medicines, and at the same time potentially increasing participant satisfaction. The current guidelines recommend changes in diet, not a potassium supplement, to increase potassium intake; hence, the two-stage design will only add supplements if the most rigorous dietary advice does not work. TRIAL REGISTRATION: This study has been registered on ClinicalTrials.gov NCT03809884 . Registered on January 18, 2019.
引用
- Hiremath S, Fergusson D, Knoll G, et al. Diet or additional supplement to increase potassium intake: protocol for an adaptive clinical trial. Trials. 2022. PMID: 35164833. doi:10.1186/s13063-022-06071-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。